ArticleClinical rheumatology2018
Correction to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.
Patrick Durez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.